Juergen Wichmann

This inventor holds 76 USPTO granted patents and 14 published patent applications, plus 5 CIPO patents and 27 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D). Top assignees: Hoffmann-La Roche Inc., C4 Therapeutics, Inc.. Active years: 2002-2026.

USPTO Granted Patents = 76 (Patent Applications = 14)

% Patents Active = 26.3

CIPO Patents = 5 (Patent Applications = 7)

EPO Patents = 27 (Patent Applications = 34)

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 130(Granted Patents)

Forward Citations (Not Self Cited) = 101(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Steinen, DE (2002 - 2020)
Basel, CH (2018 - 2020)

Company Filing History:

74 out of 5,011

Hoffmann-La Roche Inc.

patents

2 out of 39

C4 Therapeutics, Inc.

patents

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Quinazolinone Derivatives

BRAF Degraders

Neurogenic Agents

Imidazole Compounds

Pyridine Derivatives

Tetrazole Derivatives

Pyrazol Compounds

Isoquinoline Derivatives

Benzimidazoles

Carboxamides

Piperazine Compounds

Metabotropic Glutamate Antagonists

76 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570615 - Quinazolinone derivatives (2026-03-10),

2. 12559492 - BRAF degraders (2026-02-24),

3. 12486253 - Therapeutics for the degradation of mutant BRAF (2025-12-02),

4. 12116349 - Methylquinazolinone derivatives (2024-10-15),

5. 10577332 - Tetrazole derivatives (2020-03-03),

6. 10556870 - Imidazole compounds as EAAT3 inhibitors (2020-02-11),

7. 10457663 - Pyrazol-pyridine derivatives (2019-10-29),

8. 10457644 - Pyrazol compounds as EAAT3 inhibitors (2019-10-29),

9. 10273217 - Triazole derivatives (2019-04-30),

10. 10155741 - Pyridine or pyrimidine derivatives (2018-12-18),

11. 10092546 - Imidazole derivatives (2018-10-09),

12. 10029989 - Imidazole derivatives (2018-07-24),

13. 10005736 - Pyridine and pyrimidine derivatives (2018-06-26),

14. 9714239 - N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders (2017-07-25),

15. 9688675 - 1,7-naphthyridine derivatives (2017-06-27),

Title: Juergen Wichmann: Innovating in Pharmaceutical Compounds

Introduction

Juergen Wichmann, an accomplished inventor based in Steinen, Germany, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 73 patents, his work continues to advance medical science and improve therapeutic options for various conditions.

Latest Patents

Among his latest innovations are the Methylquinazolinone derivatives, which present a novel compound characterized by the general formula (I) or a pharmaceutically acceptable salt thereof. This compound has potential applications as a medicament, offering new avenues for treatment. Another noteworthy invention is the Tetrazole derivatives, addressing compounds of formula I, which further exemplifies his innovative contributions to the pharmaceutical sector.

Career Highlights

Juergen Wichmann has dedicated his professional journey to the pursuit of research and development in pharmaceuticals, working at Hoffmann-La Roche Inc. His expertise has led to the development of various compounds that exhibit significant therapeutic potential, solidifying his reputation as a leading figure in pharmaceutical research.

Collaborations

Collaboration has been a key aspect of Juergen's work. He has teamed up with notable colleagues such as Thomas Johannes Woltering and Erwin Goetschi, enhancing the collective intellectual contributions to their projects and leading to successful innovations in drug development.

Conclusion

With 73 patents to his name and ongoing contributions to the pharmaceutical field, Juergen Wichmann exemplifies the role of a dedicated inventor. His innovative compounds reflect a commitment to improving healthcare outcomes and advancing medical science, marking him as a prominent figure in his field.